Literature DB >> 32833482

Behavioral strategies to reduce stress reactivity in opioid use disorder: Study design.

R Kathryn McHugh1, Minh D Nguyen1, Garrett M Fitzmaurice2, Daniel G Dillon3.   

Abstract

OBJECTIVES: More than 2 million people in the United States had an opioid use disorder in 2017. Treatment for opioid use disorder-particularly medication combined with psychosocial support-is effective for reducing opioid use and decreasing overdose risk. However, approximately 50% of people who receive treatment will relapse or drop out. Stress reactivity, defined as the subjective and physiological response to stress, is heightened in people with opioid use disorder and higher stress reactivity is associated with poorer outcomes. Preliminary studies suggest that stress reactivity may be a key mechanistic target for improving outcomes. This article describes the design of an ongoing study examining behavioral strategies for reducing stress reactivity in adults with opioid use disorder. Our objective is to test the efficacy of two behavioral strategies for reducing stress reactivity and enhancing behavioral persistence in the context of stress (distress tolerance).
METHOD: We will recruit 120 adults with opioid use disorder and randomly assign them to brief training in (a) cognitive reappraisal, (b) affect labeling, or (c) a psychoeducational control. Participants will receive the training intervention followed by a laboratory stressor during which they will be instructed to apply the trained skill.
RESULTS: Subjective and physiological responses to stress will be measured as indices of stress reactivity and the stressor task will include a behavioral persistence component as a measure of distress tolerance.
CONCLUSIONS: The ultimate goal of this study is to inform the development of behavioral interventions that can be used as an adjunct to medication-based treatment for opioid use disorder. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 32833482      PMCID: PMC8352497          DOI: 10.1037/hea0000862

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  44 in total

1.  Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research.

Authors:  Sally S Dickerson; Margaret E Kemeny
Journal:  Psychol Bull       Date:  2004-05       Impact factor: 17.737

2.  Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.

Authors:  Antonio Verdejo-García; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2006-11-29       Impact factor: 4.530

3.  Delay-discounting probabilistic rewards: Rates decrease as amounts increase.

Authors:  K N Kirby; N N Maraković
Journal:  Psychon Bull Rev       Date:  1996-03

4.  Cognitive vulnerability to depressive symptoms in adolescents in urban and rural Hunan, China: a multiwave longitudinal study.

Authors:  John R Z Abela; Darren Stolow; Susan Mineka; Shuqiao Yao; Xiong Zhao Zhu; Benjamin L Hankin
Journal:  J Abnorm Psychol       Date:  2011-09-12

Review 5.  Dynamic adaptation of large-scale brain networks in response to acute stressors.

Authors:  Erno J Hermans; Marloes J A G Henckens; Marian Joëls; Guillén Fernández
Journal:  Trends Neurosci       Date:  2014-04-21       Impact factor: 13.837

6.  Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Authors:  Leigh V Panlilio; Samuel W Stull; William J Kowalczyk; Karran A Phillips; Jennifer R Schroeder; Jeremiah W Bertz; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; Edward V Nunes; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

7.  Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans.

Authors:  Anya K Bershad; Melissa A Miller; Greg J Norman; Harriet de Wit
Journal:  Horm Behav       Date:  2018-04-24       Impact factor: 3.587

8.  Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings.

Authors:  Rajita Sinha; Anne Kimmerling; Cheryl Doebrick; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2006-11-29       Impact factor: 4.530

Review 9.  Salivary cortisol as a biomarker in stress research.

Authors:  Dirk H Hellhammer; Stefan Wüst; Brigitte M Kudielka
Journal:  Psychoneuroendocrinology       Date:  2008-12-18       Impact factor: 4.905

10.  Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.

Authors:  Scott M Hyman; Helen Fox; Kwang-Ik A Hong; Cheryl Doebrick; Rajita Sinha
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

View more
  2 in total

1.  Future directions of the National Institutes of Health Science of Behavior Change Program.

Authors:  Chandra Keller; Rebecca A Ferrer; Rosalind B King; Elaine Collier
Journal:  Transl Behav Med       Date:  2021-04-10       Impact factor: 3.046

Review 2.  Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings.

Authors:  Lynn M Oswald; Kelly E Dunn; David A Seminowicz; Carla L Storr
Journal:  J Pers Med       Date:  2021-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.